Who invested in CamGene Therapeutics?
CamGene Therapeutics's investors include UKI2S, Parkwalk, Cambridge Enterprise Ventures, Eos and O2h Ventures, and 2 more on record.

United Kingdom · Series A startup
Funding summaryUpdated 26 Oct 2026
$5.4Mraised across 4 rounds since 2023, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Reported by Firms' own news pages
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
CamGene Therapeutics filed 4 raises, $5.4M in all. Filings say how much was sold and to how many investors; they never name the investors.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
CamGene Therapeutics's investors include UKI2S, Parkwalk, Cambridge Enterprise Ventures, Eos and O2h Ventures, and 2 more on record.
CamGene Therapeutics has raised $5.4M across 4 rounds since 2023. One round did not disclose an amount, so the total is a floor.
CamGene Therapeutics's most recent round was a Series A of $351K in May 2026.
CamGene Therapeutics's largest round on record is $4.8M (Series A), in Oct 2025.
CamGene Therapeutics's first round on record, in Nov 2025, was backed by UKI2S, Parkwalk and Cambridge Enterprise Ventures and 4 others.
CamGene Therapeutics's latest named round is a Series A, in May 2026.
CamGene Therapeutics is based in the United Kingdom.
UKI2S led the Seed in 2025.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.